Skip to main content
Trials logoLink to Trials
. 2021 Feb 16;22:145. doi: 10.1186/s13063-021-05109-8

Correction to: Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations

The UPMC REMAP-COVID Group, on behalf of the REMAP-CAP Investigators1,2
PMCID: PMC7884866  PMID: 33593400

Correction to: Trials 22, 100 (2021)

https://doi.org/10.1186/s13063-020-04997-6

Following publication of the original article [1], we were notified that a second corresponding author was missed.

The original article has been corrected to include Dr. McVerry’s email address.

Reference

  • 1.The UPMC REMAP-COVID Group, on behalf of the REMAP-CAP Investigators Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations. Trials. 2021;22:100. doi: 10.1186/s13063-020-04997-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES